spacer
home > ebr
PUBLICATIONS

European Biopharmaceutical Review

 

European Biopharmaceutical Review (EBR) is a journal designed to fill a unique position in scientific publishing. Published quarterly, it provides a dedicated platform of communication and information for the European biopharmaceutical market across Europe, North America & the rest of the world.

With editorial consisting of in-depth articles, case studies, meeting and report reviews written by specialists with hands-on experience in the biopharmaceutical industry, traditional multi-national pharmaceutical companies, investment houses and industry-associated governmental, economic and societal bodies. Each quarterly edition examines topical areas of importance across the board of biopharmaceutical research and development, with regular feature sections on BioBusiness Development, Research and Innovation, BioDiscovery, BioManufacturing plus special focuses on geographic or therapeutic territories.

For further information please contact:

Advertising

Max Garry


 

Editorial 

Jasmin Collier
  

Connect with us on Twitter: follow @EBRmagazine

Read our publications on the go in the Samedan app for iPhone and iPad. You can download issues for offline reading and our archives go as far back as 2008! Download for free on the App Store.



View the
digital version
of EBR


ebr
 
 
Featured in this issue
BUSINESS STRATEGY
In Brief

Eye of the Storm


Emile Bellott comments on the growing prominence of biosimilars, which are currently gaining visibility at the highest government levels, and some of the challenges this presents.
CANCER FOCUS
Q&A: Rare Cancer Treatments

Making Waves


As recent reports reveal that acute myeloid leukaemia a rare cancer form is expected to rise with an ageing population, Actinium Pharmaceuticals Dragan Cicic describes how a promising new radio-immunotherapy treatment could boost patient survival rates.
  CANCER FOCUS
Oncology Research

Modify This


Alfred Hansel and Martina Schmitz at oncgnostics GmbH explain the growing popularity of epigenetic modifications in cancer treatment.

spacer
Edited by
Dr Deborah O'Neil,
Chief Executive and Scientific Officer,
NovaBiotics Ltd
Published quarterly in
January, April,
July and October


 

Industry Events

RDD Asia 2016

8-11 November 2016, Grand Hyatt Hotel, Goa, India

RDD Asia 2016, jointly organized by RDD Online and Aptar Pharma, represents the extension of US and European RDD meetings into one of the world's prominent emerging markets and a hotbed of inhaler development.
More info >>

 
News and Press Releases

EMBALLAGE & MANUTENTION Exhibitions become ALL4PACK Paris


More info >>

air transport logo

 

White Papers

Assessing the Integrity of Pharmaceutical Packaging Using the Sepha Blisterscan and Conventional Blue Dye Leak Testing Methods

Sepha Limited

A new whitepaper by a leading packaging expert from the University of Ulster, Dr Dorian Dixon, into the integrity of pharmaceutical packaging has established that existing methods for testing the seal integrity of blister packs are not as accurate as newer, technology based test equipment.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement